×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Exosome and Extracellular Vesicle Brain Delivery
therapeutic
3,732 words
KG: delivery
2026-03-22
kind:therapeutic
section:therapeutics
state:published
Contents
Exosome and Extracellular Vesicle Brain Delivery
💊
Therapeutic Info
Name
Exosome and Extracellular Vesicle Brain Delivery
Summary
Page for Exosome and Extracellular Vesicle Brain Delivery
Linked Hypotheses
4 hypotheses
Knowledge Graph
Related Hypotheses (30)
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Membrane Cholesterol Gradient Modulators
Score: 0.52
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.37
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Smartphone-Detected Motor Variability Correction
Score: 0.56
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.47
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Vocal Cord Neuroplasticity Stimulation
Score: 0.50
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47
SASP-Mediated Complement Cascade Amplification
Score: 0.70
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Show 25 more
Related Experiments (10)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.46
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.46
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.46
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.46
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.46
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.46
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.46
Show 5 more
See Also (15)
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 6 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 5 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 5 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 5 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 5 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Cerebral Amyloid Angiopathy Pathway in Neurodegeneratio
mechanism · Pages share 5 hypotheses
Cerebral Amyloid Angiopathy in Neurodegeneration
mechanism · Pages share 5 hypotheses
APOE4 and Alzheimer's Disease Risk
mechanism · Pages share 5 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
Show 10 more
Knowledge Graph (1 edges)
nucleic acid-based therapeutics
associated_with
delivery